Product
Ad5-nCoV
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2020-12-31
Clinical trial
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults Aged 18 Years or Above: a Multicenter, Parallel Groups, Partially Randomized, Open-label, Blank-controlled Adaptive Platform TrialStatus: Not yet recruiting, Estimated PCD: 2024-05-18